Prostate Cancer (Adenocarcinoma) Clinical Trials in Toronto, Ontario
2 recruitingToronto, Ontario, Canada
Showing 1–2 of 2 trials
Recruiting
Phase 3
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Canadian Cancer Trials Group830 enrolled340 locationsNCT06592924
Recruiting
Not Applicable
Micro-ultrasound-Guided Focal Laser Ablation for Intermediate-Risk Prostate Cancer: Safety & Effectiveness
Prostate Cancer (Adenocarcinoma)Low and Intermediate Risk Prostate Cancer
University Health Network, Toronto7 enrolled1 locationNCT07339943